The Department of Justice’s Legal Love Letter to Moderna

This story has been retracted.

by

On December 6, 2023, the Department of Justice Office of Public Affairs sent a request for the removal of this article, stating that the article “fails to note that Mr. [Brian] Boynton is recused in this case precisely for reasons discussed in the piece.” 

In researching the Department of Justice Civil Division’s statement of interest in the patent infringement case regarding Moderna’s Covid-19 vaccine, the Revolving Door Project failed to ask the DOJ for comment on Principal Deputy Assistant Attorney Brian Boynton’s involvement in the matter. As a result, our article did not reflect the fact that Boynton did in fact recuse himself from the matter. In light of this information, the Revolving Door Project is formally retracting this article. We would like to share our sincerest apologies for not properly vetting the information shared in this article prior to its publication.

The Revolving Door Project, a Prospect partner, scrutinizes the executive branch and presidential power. Follow them at therevolvingdoorproject.org.

Unlike many news organizations, the Prospect has remained staunchly committed to keeping our journalism free and accessible to all. We believe that independent journalism is crucial for a functioning democracy—but quality reporting comes at a cost. From Trump’s threat to the free press to Musk’s influence on our democracy, there is too much at stake in 2025 to stop now.

We’re behind on our goal to raise $75,000 to continue delivering the hard-hitting investigative journalism you’ve come to expect from us. Your support helps us maintain our independence and dig deeper into the stories that matter most.

We need you to make a year-end contribution today. Any amount helps secure our future and ensure we can continue holding power to account.

Will you support independent journalism with a donation to the Prospect?